$56M sweet spot round size
Most of their 116 investments are in rounds between $22M and $100M
2004
Beta Bionics raised $100M on August 30, 2023
Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, RTW Investments, LP, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners and Omega Funds
Undisclosed raised $200M on June 8, 2023
Investors: TCG X, Samsara BioCapital, OrbiMed Advisors, Enavate Sciences, Decheng Capital, Wellington Management and Omega Funds
Bicara Therapeutics raised $108M on March 6, 2023
Investors: Bioqube Ventures, RA Capital Management, L.P., Red Tree Venture Capital, The Invus Group, Premji Invest, F-Prime Capital Partners and Omega Funds
Chroma Medicine raised $135M on March 1, 2023
Investors: Osage University Partners (OUP), Sixth Street, T. Rowe Price, Sofinnova Partners, Wellington Management, GV, Newpath Partners and Omega Funds
SoniVie Ltd raised $60M on January 9, 2023
Investors: TechWald Holding S.p.A., Supernova Invest GmbH, Andera Partners and Omega Funds
- raised $18M on November 9, 2022
Investors: Brandon Capital Partners and Omega Funds
Photys Therapeutics raised $75M on September 8, 2022
Investors: Heritage Medical Systems, Longwood Fund, MPM Capital, 8VC and Omega Funds
Undisclosed raised $39M on August 23, 2022
Investors: Grand Patika, EQT Life Sciences, FundPlus, Novalis LifeSciences LLC and Omega Funds
CDR-Life Inc. raised $76M on April 13, 2022
Investors: RA Capital Management, L.P., JEITO and Omega Funds
Aerium Therapeutics raised undisclosed on March 22, 2022
Investors: F-Prime Capital Partners and Omega Funds